Page 2 - Simon Cork News Today

Study by researchers at Canada's University of British Columbia has warned that popular weight-loss medications such as "Ozembic" increase the risk of

Using weight-loss jabs such as Ozempic or Wegovy could increase the risk of “severe gastrointestinal problems”, a study has suggested.The jabs, which have been hailed as a “game-changer” in the fight against obesity, were found to heighten th...

The study found the risks of stomach paralysis, pancreatitis, and bowel obstructions to be rare, but with tens of millions of people now taking these drugs worldwide, researchers say even

Using weight-loss medications like Wegovy can increase the risk of severe gastrointestinal problems, a study by the University of British Columbia, Canada, found.

(CNN) — A new study suggests people taking popular injected medications for weight loss, including Wegovy, Ozempic, Saxenda and Victoza, may be at higher risk for serious digestive problems such

Drugs like Ozempic, which have become increasingly popular for losing weight, heighten the risk of certain severe gastrointestinal problems including stomach paralysis, according to a large study published Thursday.The GLP-1 agonists were associated with an almost four times increased risk of stomach paralysis, a nine times higher risk of pancreatitis and four times greater risk of bowel obstruction.

A new study suggests people taking popular injected medications for weight loss, including Wegovy, Ozempic, Saxenda and Victoza, may be at higher risk for serious digestive problems such as stomach

Compared with naltrexone/bupropion for weight loss, semaglutide and liraglutide were associated with a higher risk for three adverse gastrointestinal outcomes.

GLP-1 agonists have soared in popularity in recent years as a means to lose weight

Danish pharma group Novo Nordisk's obesity drug Wegovy cuts the risk of heart attacks and strokes by a fifth, the company said in an announcement Tuesday that sent its shares soaring to a record high.